Inventor · disambiguated record
Allen Davidoff
Also filed as: DAVIDOFF ALLEN · DAVIDOFF ALLEN W
6 granted patents·6 pending applications·42 citations·filing 2005–2022
80Inventor score
Top patents by PatentIndex Score
12 records- 0194US7705036B2Deuterated aminocyclohexyl ether compounds and processes for preparing sameCARDIOME PHARMA CORP·Filed 2006·Granted Apr 27, 2010·23 cites·20 claims
- 0287US8022098B2Deuterated aminocyclohexyl ether compounds and processes for preparing sameCARDIOME PHARMA CORP·Filed 2010·Granted Sep 20, 2011·5 cites·10 claims
- 0384US7786119B2Drug conjugates of ion channel modulating compoundsCARDIOME PHARMA CORP·Filed 2005·Granted Aug 31, 2010·10 cites·6 claims
- 0477US7977373B2Prodrugs of ion channel modulating compounds and uses thereofCARDIOME PHARMA CORP·Filed 2005·Granted Jul 12, 2011·4 cites·9 claims
- 0559US8333974B2Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agentsWEISS SAMUEL·Filed 2007·Granted Dec 18, 2012·0 cites·13 claims
- 0657US2023082788A1Xanthine oxidase inhibitor formulationsXORTX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0757US2025052754A1Compositions and methods for diagnosis, treatment of and prevention of kidney diseaseXORTX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0854US11406713B2Xanthine oxidase inhibitor formulationsDAVIDOFF ALLEN·Filed 2014·Granted Aug 9, 2022·0 cites·11 claims
- 0953US2024139293A1Compositions and Methods for Enhancing Anti-Viral TherapiesXORTX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1050US2012270779A1Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disordersWEISS SAMUEL·Filed 2012·Application pending·0 cites
- 1148US2010273724A1Pegylated ion channel modulating compoundsCARDIOME PHARMA CORP·Filed 2010·Application pending·0 cites
- 1244US2023134136A1Methods of treating viral infections and health consequencesDAVIDOFF ALLEN·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →